Connect with us
European Gaming Congress 2024

Blockchain Press Releases

Single-cell Analysis Market worth $7.1 billion | MarketsandMarkets

Published

on

urban-air-mobility-market-worth-$28.5-billion-by-2030-–-exclusive-report-by-marketsandmarkets™

CHICAGO, June 22, 2023 /PRNewswire/ — The single-cell analysis industry is poised for remarkable advancements in the near future. Rapid progress in technology and innovative techniques are unlocking the immense potential of studying individual cells, revolutionizing various fields such as healthcare, biotechnology, and personalized medicine. Cutting-edge tools like single-cell RNA sequencing (scRNA-seq), mass cytometry, and microfluidics are enabling researchers to delve into the intricacies of cellular heterogeneity and uncover new insights into cellular functions, disease mechanisms, and therapeutic targets. As the cost and complexity of single-cell analysis continue to decrease, it is anticipated that this field will witness widespread adoption, leading to transformative discoveries, the development of novel diagnostics, and the identification of personalized treatment strategies. Moreover, advancements in artificial intelligence and machine learning will enhance data analysis, aiding in the interpretation of complex single-cell datasets and facilitating the translation of findings into clinical applications. The future of single-cell analysis holds tremendous promise, empowering researchers and clinicians to unravel the mysteries of cellular diversity and paving the way for a new era of precision medicine.

Single-cell Analysis Market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $7.1 billion by 2028, growing at a CAGR of 15.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as technological developments in single-cell analysis products along with increased R&D in the pharmaceutical and biotechnology sectors, growing emphasis on personalized treatment, growth in stem cell research, and the rising incidence of cancer are driving growth of single-cell analysis market. However, one of the main reasons impeding the expansion of this market is the high price of single-cell analysis equipment.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

Browse in-depth TOC on “Single-cell Analysis Market”

303 – Tables
53 – Figures
344 – Pages

Advertisement
Stake.com

Single-cell Analysis Market Scope:

Report Coverage

Details

Market Revenue in 2023

$3.5 billion

Advertisement
Stake.com

Estimated Value by 2028

$7.1 billion

Growth Rate

Poised to grow at a CAGR of 15.3%

Market Size Available for

Advertisement
Stake.com

2021-2028

Forecast Period

2023–2028

Forecast Units

Value (USD Billion)

Advertisement
Stake.com

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Product, Cell Type, Technique, Application, End User, and Region

Geographies Covered

Advertisement
Stake.com

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

High growth potential of single-cell sequencing

Advertisement
Stake.com

Key Market Drivers

Growing prevalence of cancer

 

The consumables segment accounted for the largest share of the product segment in the single-cell analysis market in 2022.

Based on product, the single-cell analysis market is broadly segmented into consumables, and instruments. In 2022, consumables accounted for the largest share of the single-cell analysis market for product. Due to the frequent purchasing of consumables as opposed to instruments, which are considered as a one-time investment, this segment has a larger market share in the market. Consumables’ numerous applications in genetic research, exosome analysis, and RNA and DNA isolation are also anticipated to fuel market expansion. Each of these applications may require specific consumables tailored to the analysis method and target molecules.

Advertisement
Stake.com

The research applications segment accounted for the largest share of the application segment in the single-cell analysis market in 2022.

Based on applications, the single-cell analysis market is categorized into two segments—medical applications and research applications. In 2022, research applications segment accounted for the largest share of single-cell analysis market. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.

Asia Pacific is likely to grow at double-digit growth rate during the forecast period.

The Asia Pacific region is estimated to grow at the highest CAGR in the single-cell analysis market during the forecast period. This can be attributed to the fast-growing pharmaceutical industry in this region, rising geriatric population, rising prevalence of cancer, and increasing government initiatives. Moreover, increasing chronic diseases in the countries of this region is likely to boost the market. Also, growing infectious diseases in the region is attracting several foreign investors in the market.  Governments in the APAC region are supporting research in various ways, such as funding research institutes and offering tax incentives to biotech and life sciences companies. This has led to an increased demand for single-cell analysis technologies to support this research.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254

Advertisement
Stake.com

Single-cell Analysis Market Dynamics:

Drivers:

  1. Technological advancements in single-cell analysis products
  2. Rising prevalence of cancer
  3. Increasing R&D in pharmaceutical & biotechnology industries for complex diseases
  4. Growth in stem cell research
  5. Growing focus on personalized medicine

Restraints:

  1. High cost of single-cell analysis products

Opportunities:

  1. High growth potential of single-cell sequencing
  2. Integration of microfluidics in single-cell analysis
  3. Emerging Asian markets

Challenges:

  1. Standardization of protocols and data integration & quality control for developing cell therapies

Key Market Players:

Some of the prominent players in the single-cell analysis market are Becton, Dickinson and Company (US), Danaher Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), 10x Genomics (US), Promega Corporation (US), Illumina, Inc. (US), Bio-Rad Laboratories (US), Standard BioTools (US), Agilent Technologies, Inc. (US), Tecan Group Ltd. (Switzerland), Sartorius AG (Germany), DiaSorin S.p.A. (Italy), Takara Bio, Inc. (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems Inc. (Italy), bioMérieux SA (France), Oxford Nanopore Technologies (UK), Cytek Biosciences (US), Corning Incorporated (US), Apogee Flow Systems Ltd. (UK), NanoCellect Biomedical (US), RareCyte, Inc. (US), and On-chip Biotechnologies Co., Ltd. (Japan).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=171955254

Recent Developments:

Advertisement
Stake.com
  • In May 2023, Becton, Dikinson and Company launched BD FACSDiscover S8 Cell Sorter, new-to-world cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells that was previously invisible in traditional flow cytometry experiments.
  • In June 2022, Merck KGaA collaborated with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.
  • In August 2021, Danaher Corporation acquired the Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher’s Life Sciences segment.

Single-cell Analysis Market Advantages:

  • Cellular Diversity and Heterogeneity: Single-cell analysis allows for the study of individual cells within a population, providing insights into the diversity and heterogeneity of cells. This enables a more comprehensive understanding of cellular development, differentiation, and responses to stimuli.
  • Enhanced Sensitivity and Resolution: Single-cell analysis techniques offer higher sensitivity and resolution compared to bulk analysis methods. They can detect rare cell types, rare genetic variants, and subtle gene expression changes that may be overlooked in aggregated samples. This sensitivity aids in the identification of biomarkers and genetic mutations associated with diseases.
  • Investigation of Complex Biological Phenomena: By dissecting the heterogeneity within tissues and organs at the single-cell level, researchers can investigate complex biological phenomena with greater precision. This includes the study of cellular signaling pathways, intercellular interactions, and the characterization of cellular networks.
  • High-Throughput Capabilities: Advancements in high-throughput technologies and automation have enabled the rapid generation of large-scale single-cell datasets. This facilitates the analysis of a large number of cells in a short period, allowing for more comprehensive studies and the identification of meaningful patterns and insights.
  • Integration with Computational Tools: Single-cell analysis data can be integrated with computational and bioinformatics tools, including machine learning algorithms. This integration enables the extraction of valuable information from complex datasets, aiding in data-driven discoveries and accelerating research progress.
  • Personalized Medicine Potential: Understanding the unique molecular profiles of individual cells paves the way for personalized medicine. By tailoring treatment strategies to individual patients based on their cellular characteristics, precision medicine can maximize therapeutic efficacy and minimize adverse effects.
  • Applications in Biomedical Research and Diagnostics: The single-cell analysis market has wide-ranging applications in biomedical research and diagnostics. It can contribute to the development of new therapies, identification of drug targets, understanding disease mechanisms, and early detection of diseases.
  • Advancements in Single-Cell Technologies: The field of single-cell analysis is rapidly evolving, with continuous advancements in technologies and techniques. This ongoing progress ensures that the advantages of single-cell analysis will only continue to expand, opening up new possibilities for research and applications in various fields.
  • Cross-disciplinary Collaboration Opportunities: Single-cell analysis brings together researchers from different disciplines, including biology, medicine, genomics, and bioinformatics. This cross-disciplinary collaboration fosters innovation, encourages the exchange of ideas and expertise, and promotes the development of novel approaches and solutions.
  • Market Growth and Commercial Potential: The single-cell analysis market is experiencing significant growth, driven by increasing demand for advanced research tools, diagnostic applications, and personalized medicine. This market growth presents commercial opportunities for companies developing and providing single-cell analysis products, services, and technologies.

Single-cell Analysis Market – Report Highlights:

  • Market sizes are updated for the base year 2022 and forecasted from 2023 to 2028.
  • Market challenges, key conferences & events in 2023–2024, and key stakeholders and buying criteria have been added to the market overview chapter.
  • The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This helps in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating country/region, and business segment focus in terms of the highest revenue-generating segment.
  • Recent developments are helpful in understanding market trends and growth strategies adopted by players in the market. In this market, the number of product launches has increased in the last three years (January 2020 to May 2023).
  • Tracking the product portfolios of prominent market players helps to analyze the products in the single-cell analysis market. The new edition of the report provides an updated product portfolio of the companies profiled in the report.
  • The market evaluation framework, market share analysis, and competitive leadership mapping of top 25 companies and 10 SMEs have been updated in the competitive landscape chapter of the report. The current version of the report includes the revenue share analysis of key market players from 2020 to 2022.
  • The updated competitive leadership mapping is an output of a comprehensive study of the key vendors offering single-cell analysis products. The top 25 vendors were shortlisted from a list of 50+ vendors, evaluated based on the market share/ranking and product footprint, rated and positioned on a 2×2 quadrant referred to as the Company Evaluation Quadrant, and categorized as Stars, Emerging Leaders, Pervasive Players, and Participants.
  • The current edition considers the impact of the recession on the single-cell analysis market.

Related Reports:

Cell Isolation Market – Global Forecasts to 2028

Cell Analysis Market – Global Forecasts to 2027

Next Generation Sequencing Market – Global Forecasts to 2027

Flow Cytometry Market – Global Forecasts to 2027

Western Blotting Market – Global Forecasts to 2026

Advertisement
Stake.com

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Advertisement
Stake.com

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/single-cell-analysis-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/single-cell-analysis.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/single-cell-analysis-market-worth-7-1-billion–marketsandmarkets-301857939.html

Continue Reading

Blockchain Press Releases

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

Published

on

janone-confirms-name-change-to-alt5-sigma-corporation-and-new-ticker-symbol-to-alts

LAS VEGAS, July 13, 2024 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company’s new name will be “ALT5 Sigma Corporation” and its Nasdaq common stock ticker symbol will change to “ALTS”. This will replace the Company’s current ticker symbol “JAN”. Further, the Company’s website address will change from “janone.com” to “alt5sigma.com.”

The Company’s change of name, ticker symbol, and website address aligns with the Company’s realignment to focus on its recently acquired, ALT5 Sigma fintech as its core engine for revenue growth.

This realignment and changes in corporate name and the ticker symbol were previously announced on July 10, 2024. No action by the Company’s stockholders is required with respect to the ticker symbol change. The Company’s CUSIP number and transfer agent will remain unchanged.

Marking the changes confirmed today, Tony Isaac, Company CEO, observed, “We are pleased to complete the changes to our name and ticker symbol as the initial steps in our previously announced diversification into fintech, while keeping our biotech’s trajectory on track, all for the benefit of our stockholders.”

About JanOne/ALT5 Sigma

Advertisement
Stake.com

The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, starting June 28, 2024.

Through its fintech activities, the Company provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, the Company offers two main platforms to its customers: “ALT5 Pay” and “ALT5 Prime”. The subsidiaries processed over US$1.2 billion in cryptocurrency transactions in 2023.

ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay’s checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named “ALT5 Pro” that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime’s FIX API, as well as through Broadridge Financial Solutions’ NYFIX gateway for approved customers.

Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation’s history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.

Advertisement
Stake.com

Forward Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5’s platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5’s services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as “continue”, “expect”, “intend”, “will”, “hope”, “should”, “would”, “may”, “potential”, and other similar expressions. Such statements reflect the Company’s current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.

Many factors could cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company’s periodic reports filed with the Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in the Company’s filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Media Contact Investor Relations
[email protected]
1-800-400-2247

Logo – https://mma.prnewswire.com/media/973662/JanOne_With_4C_TM_Logo.jpg 

Advertisement
Stake.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/janone-confirms-name-change-to-alt5-sigma-corporation-and-new-ticker-symbol-to-alts-302196185.html

Continue Reading

Blockchain Press Releases

Battle for Glory at Bybit Web3’s Ultimate Memecoin Arena: Compete to Win $50,000 in Prize Pools

Published

on

battle-for-glory-at-bybit-web3’s-ultimate-memecoin-arena:-compete-to-win-$50,000-in-prize-pools

DUBAI, UAE, July 12, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is thrilled to announce the launch of its blockchain clash competition: the Ultimate Memecoin Arena (UMA). This event will showcase a thrilling showdown between two heavyweight meme tokens, Ponke and Brett, representing Solana and Base — two blockchains battling to be the main venue for memecoin launches and trading.

Kicking off on Jul. 11, 2024, at 10AM UTC, and running through Jul. 25, 2024, participants will engage in an epic clash between Solana and Base by supporting their favorite coin from their chosen blockchain. This trading competition is not just for the individual, by siding with the top team, participants will grab the Ultimate Prize Pool for their team.

Prize Pools:

  1. PONKE Prize Pool: $12,500 worth of PONKE tokens
    1. Eligibility: Trade at least $300 worth of PONKE tokens to qualify for a share of this pool.
  2. BRETT Prize Pool: $12,500 worth of BRETT tokens
    1. Eligibility: Trade at least $300 worth of BRETT tokens to qualify for a share of this pool.
  3. Ultimate Prize Pool: $25,000 worth of PONKE & BRETT tokens
    1. The pool with the highest trading volume will win the entire Ultimate Prize Pool.
    2. Rewards will be distributed among participants who have traded at least $300 of the winning token.

How to Participate:

  1. Prepare your Bybit Cloud Wallet or any Seed Phrase Wallet.
  2. Transfer SOL to your wallet for the PONKE Prize Pool or WETH for the BRETT Prize Pool.
  3. Swap at least $300 worth of PONKE or BRETT tokens to be eligible for their respective prize pools.
  4. Engage in trading to contribute to the Ultimate Prize Pool.

The trading competition is the first to be held on Bybit Web3 DEX Pro, a revolutionary decentralized exchange with over 1 million tokens to trade modeled after Bybit’s institutional-grade trading interface. Bybit Web3 DEX Pro surpasses typical CEX offerings, equipping users with i-SMART data intelligence technology. This powerful suite provides traders with on-chain and social media data, allowing them to make informed and smarter decisions.

“This competition is about embracing the excitement and community spirit of the crypto world,” said MK Chin, Bybit Web3 evangelist. “We’re excited to see how participants strategize and trade their way to victory in this thrilling competition.”

Don’t miss your chance to participate in the Ultimate Memecoin Arena and compete for glory and substantial rewards. Join Bybit in the battle of the meme tokens and trade your way to victory!

Advertisement
Stake.com

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving over 33 million users. Established in 2018, Bybit provides a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.

For media inquiries, please contact: [email protected]

Advertisement
Stake.com

For more information, please visit: https://www.bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Bybit Logo

Photo – https://mma.prnewswire.com/media/2460020/Image.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/battle-for-glory-at-bybit-web3s-ultimate-memecoin-arena-compete-to-win-50-000-in-prize-pools-302195749.html

Continue Reading

Blockchain Press Releases

Bybit Web3 and Ignition Join Forces to Bridge the Gap Between Bitcoin and Ethereum

Published

on

bybit-web3-and-ignition-join-forces-to-bridge-the-gap-between-bitcoin-and-ethereum

DUBAI, UAE, July 12, 2024 /PRNewswire/ — Bybit, the world’s second-largest web3 platform by trading volume, breaks down barriers between Bitcoin and the Ethereum Virtual Machine (EVM) ecosystems with its partnership of Ignition. Supported by core contributors Mantle and Antalpha Prime, Ignition is paving the way for a low-friction and interoperable future. It extends Bitcoin’s functionality beyond its traditional role as a store of value and transforms it into a reliable asset for cross-chain integrations and diverse yield opportunities.

Bybit Web3 Wallet will support FBTC, an omnichain Bitcoin asset pegged 1:1 to BTC, introduced by Ignition. This strategic collaboration empowers users to unlock the full potential of Bitcoin within the thriving EVM ecosystem, reflecting Bybit Web3’s philosophy of openness, simplicity, and equality.

“We are thrilled to partner with Ignition, which aligns with Bybit’s mission to provide users with innovative and seamless DeFi solutions. By integrating Ignition and FBTC, we are not only enhancing liquidity and interoperability but also paving the way for a more inclusive and dynamic crypto ecosystem,” added MK Chin, Bybit Web3 Evangelist.

FBTC: Bridging the Divide between Bitcoin and non-Bitcoin Ecosystems in Web3

Introduced by Ignition, FBTC is an omnichain Bitcoin asset pegged 1:1 to BTC aimed at elevating Bitcoin’s accessibility and utility. As a secure, decentralized, and composable liquid Bitcoin asset with deep liquidity, $FBTC can be used at scale and easily integrated into various yield enhancement strategies like liquidity pooling, collateral, and staking.

Advertisement
Stake.com

Under Ignition, $FBTC’s growth will be driven by a comprehensive roadmap and strong developer support, ensuring its long-term success and sustainable growth.

Bybit Web3: A Partnership for Enhanced DeFi and User Opportunities

Bybit is at the forefront of adopting the Ignition ecosystem, reinforcing Bybit’s commitment to pioneering innovative solutions for the crypto community. Bybit Web3 users will now have access to a multitude of products and opportunities within the burgeoning Ignition space. 

This integration unlocks a range of benefits for users:

  • Enhanced Liquidity: FBTC opens the door to increased liquidity, allowing users to trade and invest in Bitcoin with greater ease within the EVM ecosystem.
  • Diverse Yield Opportunities: Users can explore a variety of attractive yield-generating strategies with FBTC, maximizing the earning potential of their Bitcoin holdings.
  • Seamless Interoperability: FBTC bridges the gap between various blockchain networks, ensuring users can move their assets freely and efficiently.

Coming Soon: Swap and Staking on FBTC

Bybit Web3 users can look forward to using their Bybit Web3 Wallet to swap and stake on FBTC in the later half of July. For more information, please visit: https://www.bybit.com/en/web3/home

Advertisement
Stake.com

#Bybit / #TheCryptoArk / #BybitWeb3

About Bybit Web3

Bybit Web3 is redefining openness in the decentralized world, creating a simpler, open, and equal ecosystem for everyone. We are committed to welcoming builders, creators, and partners in the blockchain space, extending an invitation to both crypto enthusiasts and the curious, with a community of over 10 million wallet users, over 20 major ecosystem partners, and counting. 

Bybit Web3 provides a comprehensive suite of Web3 products designed to make accessing, swapping, collecting and growing Web3 assets as open and simple as possible. Our wallets, marketplaces and platforms are all backed by the security and expertise that define Bybit as a top 3 global crypto exchange, trusted by 33 million users globally.

Join the revolution now and open the door to your Web3 future with Bybit.

Advertisement
Stake.com

For more details about Bybit, please visit Bybit Web3.

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving over 33 million users. Established in 2018, Bybit provides a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.
For media inquiries, please contact: [email protected]
For more information, please visit: https://www.bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Advertisement
Stake.com
Bybit Web3 Logo

Photo – https://mma.prnewswire.com/media/2459975/Image.jpg
Logo – https://mma.prnewswire.com/media/2311075/Bybit_Web3_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit-web3-and-ignition-join-forces-to-bridge-the-gap-between-bitcoin-and-ethereum-302195724.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE